BMVision AI for CT Radiology

Better Medicine OÜ is a radiology AI company headquartered in Tartu, Estonia and founded in 2020, according to an August 2025 funding report. It helps radiologists detect, measure and report oncological findings on CT scans, a repetitive and time-consuming task.

Its BMVision suite includes Kidney and Lung modules for AI lesion detection, a semi-automated iMeasure tool, a custom viewer called BMViewer and a gateway called BMGateway. The Kidney module carries CE certification as a Class IIa device. Partners and sites listed include Universitatsmedizin Mainz, NHS, Tartu University Hospital and deepc.

• Lesion detection: AI detection of lesions on CT scans for kidney and lung.
• iMeasure: semi-automated lesion measurement.
• Automated reporting: generates structured oncological findings reports.
• BMViewer: custom-built image viewer.
• BMGateway: connects the AI to hospital imaging infrastructure.
• PACS integration: works with existing PACS and standard viewers.

Large Vietnamese hospitals could use it to support CT reading for kidney and lung findings. Cancer centers could use iMeasure for follow-up lesion measurement. Local regulatory registration would be required first.

Clinical evaluations cited in the funding report show up to 52% time savings and a 99.2% detection rate for the Kidney module. Solutions are CE-marked and the quality system is ISO 13485. The software integrates with existing PACS and standard viewers.

Radiology workloads are growing faster than the supply of radiologists, which drives demand for AI detection and measurement tools. Vietnamese hospitals expanding CT-based cancer screening face similar reading backlogs, subject to local regulatory clearance.

Better Medicine OÜ, Tartu, Estonia, founded 2020. Nearly EUR 6 million total funding reported August 2025, led by Soulmates Ventures, plus a EUR 2.5 million European Innovation Council award. CE-marked Class IIa Kidney module; ISO 13485.